SCHEMBL4756199

SCHEMBL4756199

CS(=O)(=O)Oc1ccc(C(=O)Nc2nccs2)cc1F

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.62
SMN1; SMN2 Q16637 5/20 0.62
MAPK1 P28482 1/20 0.62
ADORA2A P29274 2/20 0.55
ADORA1 P30542 2/20 0.55
NPC1 O15118 9/20 0.53
MAPT P10636 3/20 0.53
POLB P06746 3/20 0.53
HSD17B10 Q99714 2/20 0.53
ESR2 Q92731 1/20 0.53
ALDH1A1 P00352 2/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
BRD4 O60885 1/20 0.51
TDP1 Q9NUW8 1/20 0.50
LMNA P02545 1/20 0.50
RECQL P46063 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
HPGD P15428 1/20 0.50
ADORA2B P29275 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL706414 0.81 RAB9A (0.71) RAB9ASMN1; SMN2MAPK1ADORA2ANPC1
SCHEMBL4755922 0.79 RAB9A (0.71) RAB9ASMN1; SMN2MAPK1NPC1HSD17B10
SCHEMBL3199881 0.77 RAB9A (0.66) RAB9ASMN1; SMN2MAPK1ADORA2AADORA1
SCHEMBL703469 0.76 ALOX15 (0.70) RAB9ASMN1; SMN2MAPK1ADORA2ANPC1
SCHEMBL4292567 0.75 RAB9A (0.59) RAB9ASMN1; SMN2MAPK1ADORA2AADORA1
SCHEMBL4756204 0.74 SMN1; SMN2 (0.52) RAB9ASMN1; SMN2MAPK1NPC1MAPT
SCHEMBL9963854 0.73 RAB9A (0.89) RAB9ASMN1; SMN2MAPK1NPC1MAPT
SCHEMBL3188607 0.73 NPC1 (0.65) RAB9ASMN1; SMN2MAPK1ADORA2AADORA1
SCHEMBL3196687 0.72 NPC1 (0.62) RAB9ASMN1; SMN2ADORA2AADORA1NPC1
SCHEMBL1119373 0.72 RAB9A (0.71) RAB9ASMN1; SMN2MAPK1ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
WO-2009035788-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. (US) 2009-03-19 WO disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC RAB9A 1694/4885SMN1; SMN2 3410/4885MAPK1 3595/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC RAB9A 1694/4885SMN1; SMN2 3410/4885MAPK1 3595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.